121
Participants
Start Date
May 31, 1999
Study Completion Date
October 31, 2006
Ritonavir
Abacavir sulfate
Amprenavir
Lamivudine
Stavudine
Beth Israel Med. Ctr. ACTU, New York
NY Univ. HIV/AIDS CRS, New York
Columbia P&S CRS, New York
AIDS Care CRS, Rochester
McCree McCuller Wellness Ctr. at the Connection, Infectious Disease Unit, Rochester
Univ. of Rochester ACTG CRS, Rochester
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
Unc Aids Crs, Chapel Hill
Washington U CRS, St Louis
University of Colorado Hospital CRS, Aurora
USC CRS, Los Angeles
UCLA CARE Center CRS, Los Angeles
Ucsd, Avrc Crs, San Diego
Ucsf Aids Crs, San Francisco
Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu
Massachusetts General Hospital ACTG CRS, Boston
SSTAR, Family Healthcare Ctr., Fall River
The Miriam Hosp. ACTG CRS, Providence
National Institute of Allergy and Infectious Diseases (NIAID)
NIH